• Discounts and special offers
  • Subscriber-only articles and interviews
  • Breaking news and trending topics

Already a subscriber?

By signing up, you accept Moneywise's Terms of Use, Subscription Agreement, and Privacy Policy.

Not interested ?

Investing Basics
CBD stocks surged on Trump’s Medicare comments, but uncertainty around drug reclassification and policy changes still clouds the industry’s long-term future. SAUL LOEB/Getty Images

Cannabis stocks soared 36% after Trump’s CBD Medicare signal sparks investor interest — should you hold for the long run or brace for policy risks?

Cannabis investors recently saw a jolt of optimism after President Donald Trump signaled support for covering CBD oil under Medicare. With the news, stock prices soared.

A few of the companies that saw their stock prices soar up to 36% after the news include Green Thumb Industries, Curaleaf Holdings, Innovative Industrial Properties, Tilray Brands and Canopy Growth. (1)

Advertisement

All of this growth came after The Commonwealth Project released a video touting the benefits of CBD oil for seniors. Subsequently, Trump shared this video on Truth Social, a signal of support. (2) But somewhat uncharacteristically, he didn’t add any commentary in his post; he simply shared the video.

Back in August, Trump shared that he was considering reclassifying marijuana as a less dangerous substance. (1) But, so far, nothing official has moved forward that would reclassify marijuana and potentially open the door to more prevalent use in the medical industry.

The future of CBD still uncertain

The video’s narrator states, “it’s time to educate doctors on the endocannabinoid system, provide Medicare coverage for CBD and give millions of seniors the support they deserve.” It also highlighted Trump’s role in signing the 2018 Farm Bill, which helped open the door for production and sales of CBD across the country. (3)

Trump shared a video that proclaimed the benefits of CBD oil. But, notably, he didn’t say anything about the contents of the video. Instead, he shared it through Truth Social without any additional commentary.

Many may rightly see this as a sign of support for covering CBD oil under Medicare, which pushed CBD stock prices higher. But the president hasn’t explicitly stated anything that would indicate this is his goal, and more pressingly for investors, there’s no firm timeline.

It’s critical to remember that nothing is finalized. Any political or legal challenges could derail the industry’s progress, which means investors cannot assume smooth sailing anytime soon.

Unfortunately, the lack of clarity means that investors cannot know for sure that this signal from the president means they can relax. With that, it seems likely the stock prices in the cannabis industry will remain volatile for the foreseeable future.

Must Read

Join 250,000+ readers and get Moneywise’s best stories and exclusive interviews first — clear insights curated and delivered weekly. Subscribe now.

Should you add CBD stocks to your portfolio?

Volatility in the stock market isn’t a new phenomenon. It can impact almost any industry. But some sectors, like tech and consumer discretionary, seem especially prone to market volatility.

Advertisement

Most investors expect market volatility in their investment journey. Recently, a Gallup survey found that 73% of investors expected market volatility to persist through the end of 2025. (4) Although that survey covers the market in general, it does shed light on the fact that dealing with volatility is a part of being an investor.

One way to deal with volatility is to craft an investment portfolio with the long-term in mind. Buy-and-hold investing isn’t necessarily an exciting strategy. But it’s an option that works well for many investors.

If considering adding CBD stocks to your portfolio, buying and holding for the long term might be a good idea for investors who believe in the future of this industry.

When opting for a long-term approach, consider opting for an ETF instead of buying into individual companies. The right ETF will help you gain exposure to CBD without putting all of your eggs into the basket of a single company. Some possible ETFs to consider include AdvisorShares Vice ETF (VICE) and Cambria Cannabis ETF (TOKE).

Depending on how things play out, buying into the industry now could pay off in the long run. But as with all investment possibilities, only time will tell.

Article sources

We rely only on vetted sources and credible third-party reporting. For details, see our editorial ethics and guidelines.

New York Post (1); Truth Social (2); Congress.gov (3); The Hill (4)

You May Also Like

Share this:
Sarah Sharkey Contributor

Sarah Sharkey is a personal finance writer who enjoys helping people make optimal financial decisions for their situation. She loves digging into the nitty-gritty details of financial products and money management strategies to root out the good, the bad, and the ugly. Her goal is to help readers find the best course of action for their needs.

more from Sarah Sharkey

Explore the latest

Disclaimer

The content provided on Moneywise is information to help users become financially literate. It is neither investment, tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities, enter into any loan, mortgage or insurance agreements or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter. Advertisers are not responsible for the content of this site, including any editorials or reviews that may appear on this site. For complete and current information on any advertiser product, please visit their website.

†Terms and Conditions apply.